Physician profile
Ethan Munzinger
NPI 1427343185
$23,003.56
in general payments reported to CMS, 2019-2025
33 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,325 · 2020: $1,740 · 2021: $4,177 · 2022: $7,249 · 2023: $599 · 2024: $4,488 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,349 · Food and Beverage: $2,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,349.33 |
| Food and Beverage | $2,163.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $8,840.52 | 2021-2022 | |
| Medtronic, INC. | $4,148.24 | 2021-2025 | Advisa Dr Mri Surescan, Adapta, Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $3,842.49 | 2019-2020 | |
| Cardiovascular Systems INC. | $1,528.64 | 2019-2022 | |
| Abbott Laboratories | $689.38 | 2019-2022 | |
| Avinger INC. | $635.35 | 2020-2022 | |
| Boston Scientific Corporation | $615.32 | 2019-2025 | Varithena Administration Pack, Watchman Access System, Eluvia |
| Shockwave Medical, INC | $511.77 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $510.70 | 2019-2020 | |
| Acist Medical Systems, INC. | $221.47 | 2019 | |
| Inari Medical, INC. | $221.26 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $204.34 | 2019-2022 | |
| Philips North America LLC | $202.83 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.54 | 2019-2024 | Lifevest |
| Amgen INC. | $108.35 | 2020-2025 | Repatha, Repatha |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $81.41 | 2024 | |
| Tactile Systems Technology INC | $73.17 | 2024 | Entre Plus, Flexitouch Plus |
| Novartis Pharmaceuticals Corporation | $48.34 | 2023-2024 | |
| Livanova USA, INC. | $44.64 | 2019-2020 | |
| Koya Medical, INC. | $44.63 | 2025 | Koya Medical, Dayspring |
| Baxter Healthcare | $44.34 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $41.11 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $30.30 | 2020-2024 | Camzyos |
| Nipro Medical Corporation | $26.37 | 2025 | Hemodialysis System |
| Janssen Pharmaceuticals, INC | $24.14 | 2019 | |
| Merck Sharp & Dohme LLC | $23.74 | 2024 | Verquvo |
| Cordis US Corp. | $19.36 | 2022 | |
| Cardiva Medical, INC. | $18.17 | 2025 | Optowire |
| Heartflow, INC. | $15.85 | 2025 | |
| Irhythm Technologies, INC. | $15.73 | 2019 | |
| Cook Medical LLC | $13.00 | 2020 | |
| Pfizer INC. | $12.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Munzinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.